Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chemed Corporation (CHE)
NYSE:CHE
Holding CHE?
Track your performance easily
Earnings Data
Report Date
Feb 25, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
$6.78Last Year’s EPS
$6.6Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 29, 2024
|% Change Since: -14.13%
|Next Earnings Date:Feb 25, 2025
Earnings Call Sentiment|Neutral
The earnings call reflects strong performance and growth prospects for VITAS, driven by increased admissions and successful integration of Covenant Health. However, significant challenges are evident in Roto-Rooter's declining revenue and call volumes, leading to a reduction in overall EPS guidance.Company Guidance
During the Chemed Corporation Q3 2024 earnings call, the executives presented several key metrics and guidance insights. VITAS Healthcare Corporation, a subsidiary of Chemed, reported a significant 17.3% increase in net revenue, reaching $391.4 million, driven by a 15.5% increase in days of care and a 2.6% rise in Medicare reimbursement rates. The average daily census at VITAS grew by 15.5%, totaling 21,785 patients, while admissions increased by 6.3% to 16,775. The acquisition of Covenant Health contributed between $10 million and $11 million to revenue, translating into a net income of approximately $1.8 million to $2 million. On the other hand, Roto-Rooter faced challenges with a 6.9% decline in quarterly revenue to $214.8 million, attributed to an 11.7% drop in call volume and a 6.3% decrease in residential revenue. Despite these challenges, Chemed's adjusted earnings per diluted share guidance was revised to $23 to $23.15, still reflecting a 13.3% to 14% increase over the previous year. The company expressed optimism for VITAS, bolstered by strong growth metrics and strategic expansions, while acknowledging operational hurdles at Roto-Rooter, with efforts underway to address marketing and demand challenges.VITAS Admissions and Revenue Growth
VITAS reported a 6.3% increase in admissions and a 15.5% increase in average daily census. Net revenue increased by 17.3% to $391.4 million, driven by a 15.5% increase in days of care and a 2.6% Medicare reimbursement rate increase.
Successful Covenant Health Acquisition
The $85 million acquisition of Covenant Health is meeting all internal financial projections and contributed $10 to $11 million of revenue in the third quarter.
Positive Outlook for VITAS
VITAS has achieved nine consecutive quarters of workforce expansion and eight quarters of average daily census growth, indicating strong performance and future growth potential.
---
CHE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
CHE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 29, 2024 | $609.25 | $535.32 | -12.13% |
| Jul 24, 2024 | $546.52 | $540.02 | -1.19% |
| Apr 24, 2024 | $616.41 | $571.91 | -7.22% |
| Feb 27, 2024 | $595.11 | $627.27 | +5.40% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Chemed Corporation (CHE) report earnings?
Chemed Corporation (CHE) is schdueled to report earning on Feb 25, 2025, TBA Not Confirmed.
What is Chemed Corporation (CHE) earnings time?
Chemed Corporation (CHE) earnings time is at Feb 25, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CHE EPS forecast?
CHE EPS forecast for the fiscal quarter 2024 (Q4) is $6.78.
---